Fast-Track Zika Vaccine Development - Is It Possible?
From the Walter Reed Army Institute of Research, Silver Spring, MD (S.J.T.); Sanofi Pasteur, Lyon, France (M.L., N.A.C.J.); and the Sealy Center for Vaccine Development and Department of Pathology, University of Texas Medical Branch, Galveston (A.D.T.B.).
Stephen J
SJ
Thomas
From the Walter Reed Army Institute of Research, Silver Spring, MD (S.J.T.); Sanofi Pasteur, Lyon, France (M.L., N.A.C.J.); and the Sealy Center for Vaccine Development and Department of Pathology, University of Texas Medical Branch, Galveston (A.D.T.B.).
Maïna
M
L'Azou
From the Walter Reed Army Institute of Research, Silver Spring, MD (S.J.T.); Sanofi Pasteur, Lyon, France (M.L., N.A.C.J.); and the Sealy Center for Vaccine Development and Department of Pathology, University of Texas Medical Branch, Galveston (A.D.T.B.).
Alan D T
AD
Barrett
From the Walter Reed Army Institute of Research, Silver Spring, MD (S.J.T.); Sanofi Pasteur, Lyon, France (M.L., N.A.C.J.); and the Sealy Center for Vaccine Development and Department of Pathology, University of Texas Medical Branch, Galveston (A.D.T.B.).
Nicholas A C
NA
Jackson
D002648:Child; D002986:Clinical Trials as Topic / Q000379:methods*; D017277:Drug Approval; D058872:Epidemics / Q000517:prevention & control; D005260:Female; D006801:Humans; D008297:Male; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control; D014765:Viral Vaccines / Q000276:immunology; D000071244:Zika Virus; D000071243:Zika Virus Infection / Q000453:epidemiology / Q000517:prevention & control*
D014765:Viral Vaccines